TORONTO, Jan. 29, 2018 /CNW/ - The Canadian life and health insurance industry welcomes today's joint announcement by thePan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) that they have come to an agreement to reduce prices for generic drugs by 25-40%.
"This is wonderful news and we're especially pleased that
The CLHIA congratulates the pCPA and the CGPA on their cooperative approach to finding a meaningful solution to maintain the sustainability of our prescription drug system. The CLHIA believes that innovative government and private sector partnership agreements such as this are the best way forward to ensuring the affordability of prescription drugs for all Canadians.
About the CLHIA
The CLHIA is a volunteer association whose member companies account for 99% of Canada's life and health insurance business. The industry provides a wide range of financial security products such as life insurance, annuities (including RRSPs, RRIFs and pensions) and supplementary health insurance to more than 28 million Canadians. It also holds over $810 billion in assets in Canada and employs nearly 155,000 Canadians.
SOURCE Canadian Life and Health Insurance Association Inc.
Subscribe to our Free Newsletters!
Bad eating habits will affect your health as well as your skin and make you look older than your ...
A lump in the armpit can be due to a benign infection, allergy or fatty tissue growth. It is ...
Fennel seeds are a must-have in almost every Indian kitchen due to its health quotient. Here are a ...View All